about
ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapiesReducing myocardial infarct size: challenges and future opportunitiesParkinson's disease proteins: Novel mitochondrial targets for cardioprotectionMitochondrial dynamics in cardiovascular health and diseaseRemote ischemic conditioning: from experimental observation to clinical application: report from the 8th Biennial Hatter Cardiovascular Institute WorkshopRole of the MPTP in conditioning the heart - translatability and mechanismCardioprotection during cardiac surgeryInteraction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioningMitochondrial fusion and fission proteins as novel therapeutic targets for treating cardiovascular diseaseBlood pressure oscillations during tilt testing as a predictive marker of vasovagal syncope.Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury.Preconditioning protects by inhibiting the mitochondrial permeability transition.Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection.Is there a role for ischaemic conditioning in cardiac surgery?Quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance.Full left ventricular coverage is essential for the accurate quantification of the area-at-risk by T1 and T2 mapping.Hypoxia signaling controls postnatal changes in cardiac mitochondrial morphology and function.The novel adipocytokine visfatin exerts direct cardioprotective effectsMitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning.Mitochondrial morphology and cardiovascular diseasePeri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection.Leptin-induced cardioprotection involves JAK/STAT signaling that may be linked to the mitochondrial permeability transition pore.Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations.New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway.Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials.Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery.Myocardial reperfusion injury.Loss of PINK1 increases the heart's vulnerability to ischemia-reperfusion injury.Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening.Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.Metformin prevents myocardial reperfusion injury by activating the adenosine receptor.A retrospective analysis of myocardial preservation techniques during coronary artery bypass graft surgery: are we protecting the heart?Cardiovascular magnetic resonance in cardiac sarcoidosis with MR conditional pacemaker in situ.Preconditioning Shields Against Vascular Events in Surgery (SAVES), a multicentre feasibility trial of preconditioning against adverse events in major vascular surgery: study protocol for a randomised control trial.Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study design.T1 mapping and T2 mapping at 3T for quantifying the area-at-risk in reperfused STEMI patientsMitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failureCyclosporin A and cardioprotection: from investigative tool to therapeutic agent.The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning.Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore.
P50
Q24289195-3EE65CAF-B2A5-4BA1-A954-65551D53A268Q26775395-831BB9BB-B28C-4289-BB76-28A518879666Q26781796-24C5E52A-7EBA-40FA-9199-BDD5A24344E4Q26820835-BA9F25E0-9379-4012-940B-BCFBBCDD71E2Q26828968-D089AAD8-8C3E-4FF1-9AAC-8FD01AA44E35Q26830560-74C1DA74-B1CF-4B80-AD51-03439EB3F020Q26866366-B80004A0-89A3-4C75-A1B0-D9D8443CFABCQ26995004-F19FF25B-6672-423A-8C19-70696D827F1DQ28084134-ABF6DB7D-1E2C-4DBE-AFAA-43A04897CC4BQ33158010-B48D4C05-5674-4A8C-9365-837F4012BC08Q33195698-2A9A46CC-21F5-4B8F-8899-1E1649D9A324Q33201290-3AA71F8A-9B1B-4268-B2E1-A71815D0CADEQ33226934-276D395A-DE04-4444-95DE-E73C8AD6A671Q33605260-A39129F3-4DDB-4402-A47C-80A1D144849DQ33720141-0A4F6964-84AD-4C12-B26F-222861B2A65EQ33884781-D0379FDE-0F91-4B6A-9FC2-FFD3F69D82C2Q34001111-3EC6426B-FD7F-45B5-8A1E-F2542715B496Q34001681-91EEB60E-83D3-4832-A682-0290DC8273F9Q34113365-7D5ACEA7-763D-4D80-B462-E25144C3311EQ34113390-2FE300B0-51E8-4FB2-AA0A-1D6E7BC388E6Q34147112-3E503817-2B4A-4614-A393-FDCDFDFA0056Q34212278-32F028F4-9051-4FFE-A4EE-8F175F3BED6CQ34247485-865FCBF6-48A8-42CA-A6AD-CB2E571FC7EFQ34298555-3729949D-98C6-481D-99A9-F6F741567136Q34349214-A12D27BC-DF5A-42DA-8C43-CEC0348494B5Q34496755-1A8B87D8-7173-4158-B70F-C56BB3C71526Q34687124-1635BB7F-D4A9-4342-90BE-28BE8D8CE546Q34701379-355FE264-CEAD-4F15-AEA1-C3D60881D0DAQ34725613-AA4BFC62-7579-4CED-A50F-CA2853379533Q34778664-8215117B-87C6-4EBE-9243-A54AE85A6A86Q34964594-51682C90-DD8A-46FE-B8A6-17999E970C72Q34995261-6C54999B-21EE-4379-AB21-FE8A40EB1A3FQ35027202-91AE8F93-032E-4FA2-B796-E80EFAF290D6Q35552969-E746B70D-387A-4357-941E-A4F942D4D4FEQ35810347-2E9A39EF-6EDD-4096-82A9-316EC3AC2DC1Q35945907-CFCF81CE-43C6-491A-B4F6-4892F6C80F14Q35953116-BB4A0099-ADAA-42D0-B769-12043923DADEQ35953116-D3F14D3F-8D77-4EB6-AE12-8565C1D2B7F6Q36024824-2F8D2A1C-DF8A-4182-97AA-E91E66737444Q36122804-EE608DA4-5135-41EE-80F1-C0E5DCEE4571
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Derek J Hausenloy
@ast
Derek J Hausenloy
@en
Derek J Hausenloy
@es
Derek J Hausenloy
@nl
Derek J Hausenloy
@sl
type
label
Derek J Hausenloy
@ast
Derek J Hausenloy
@en
Derek J Hausenloy
@es
Derek J Hausenloy
@nl
Derek J Hausenloy
@sl
prefLabel
Derek J Hausenloy
@ast
Derek J Hausenloy
@en
Derek J Hausenloy
@es
Derek J Hausenloy
@nl
Derek J Hausenloy
@sl
P214
P244
P101
P106
P21
P214
P244
nb2011005406
P2798
P31
P496
0000-0003-0729-4956
P7859
lccn-nb2011005406